Heat Shock Protein 90 Alpha: A Potential Drug Target (G441051)

Target Name: HSP90AA6P

NCBI ID: G441051

HSP90AA6P

Other Name(s): heat shock protein 90 alpha family class A member 6, pseudogene | Heat shock protein 90 alpha family class A member 6, pseudogene | HSP90Af

Heat Shock Protein 90 Alpha: A Potential Drug Target

Heat shock protein 90 alpha (HSP90伪) is a protein that is expressed in various cell types and is involved in a variety of cellular processes. HSP90伪 has been identified as a potential drug target and has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The HSP90伪 protein is a member of the HSP90伪 family, which is a group of proteins that are involved in the regulation of thermal stability. These proteins are expressed in a variety of cell types, including muscle, nerve, heart, and cancer cells. HSP90伪 is a 21-kDa protein that is expressed in a variety of tissues, including the brain, heart, liver, and kidney.

HSP90伪 is involved in a number of cellular processes that are related to stress and damage tolerance. For example, it has been shown to play a role in the regulation of cellular stress responses, including the stress-induced transition toG1 cell cycle arrest and the regulation of apoptosis. HSP90伪 has also been shown to play a role in the regulation of inflammation, including the regulation of the production of pro-inflammatory cytokines.

In addition to its role in cellular stress and damage tolerance, HSP90伪 has also been shown to play a role in a number of diseases. For example, it has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. HSP90伪 has also been shown to be involved in the development and progression of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis.

Due to its involvement in a number of cellular processes that are related to stress and damage tolerance, HSP90伪 has been identified as a potential drug target. Several studies have shown that inhibiting HSP90伪 can have a variety of therapeutic effects, including the inhibition of cancer cell growth and the inhibition of neurodegenerative disease progression. In addition, HSP90伪 has also been shown to play a role in the regulation of inflammation, and inhibiting it has been shown to have a variety of therapeutic effects, including the inhibition of pro-inflammatory cytokine production.

There are a number of different methods that have been used to inhibit HSP90伪, including inhibitors of its synthesis, its translation, and its function. These compounds have been shown to have a variety of therapeutic effects, including the inhibition of cancer cell growth, the inhibition of neurodegenerative disease progression, and the inhibition of inflammation. In addition, some of these compounds have also been shown to have potential clinical applications, including the treatment of cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, HSP90伪 is a protein that is involved in a variety of cellular processes that are related to stress and damage tolerance. It has been identified as a potential drug target and has been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In addition, HSP90伪 has also been shown to play a role in the regulation of inflammation, and inhibiting it has been shown to have a variety of therapeutic effects. Further research is needed to fully understand the role of HSP90伪 in disease and to develop effective treatments.

Protein Name: Heat Shock Protein 90 Alpha Family Class A Member 6, Pseudogene

The "HSP90AA6P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSP90AA6P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets